Friday, June 19, 2026

EPS

February 10, 2022

Britain’s AstraZeneca posts revenue boost, with 2.5 billion COVID-19 jabs released

The company’s total revenue increased by 41 per cent in 2021, while core earnings per share grew by 32 per cent.

AstraZeneca headquarters